New filings with the Securities and Exchange Commission are requesting permission to launch ETFs that hold both public and private assets.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
What’s a good gift for a mature bull? How about a dose of perspective? The stock market can sometimes be a victim of its own recent success.
By licensing a drug from Hansoh, Merck signaled that it isn’t prepared to fully challenge its rivals’ dominance in the GLP-1 space.
If similar cases are a guide, the US has given equal weight to both known and hypothetical threats to national security.
With Trump expected to chase increased oil exports and more drilling in the US, OPEC+’s fear of losing market share looms larger than ever.